220 related articles for article (PubMed ID: 23151747)
21. Application of an E. coli signal sequence as a versatile inclusion body tag.
Jong WS; Vikström D; Houben D; van den Berg van Saparoea HB; de Gier JW; Luirink J
Microb Cell Fact; 2017 Mar; 16(1):50. PubMed ID: 28320377
[TBL] [Abstract][Full Text] [Related]
22. A support vector machine-based method for predicting the propensity of a protein to be soluble or to form inclusion body on overexpression in Escherichia coli.
Idicula-Thomas S; Kulkarni AJ; Kulkarni BD; Jayaraman VK; Balaji PV
Bioinformatics; 2006 Feb; 22(3):278-84. PubMed ID: 16332713
[TBL] [Abstract][Full Text] [Related]
23. Efficient solubilization and purification of highly insoluble membrane proteins expressed as inclusion bodies using perfluorooctanoic acid.
Plucinsky SM; Root KT; Glover KJ
Protein Expr Purif; 2018 Mar; 143():34-37. PubMed ID: 29066155
[TBL] [Abstract][Full Text] [Related]
24. Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies.
Lee HJ; Im H
Protein Expr Purif; 2003 Sep; 31(1):99-107. PubMed ID: 12963346
[TBL] [Abstract][Full Text] [Related]
25. Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginine.
Tsumoto K; Umetsu M; Kumagai I; Ejima D; Arakawa T
Biochem Biophys Res Commun; 2003 Dec; 312(4):1383-6. PubMed ID: 14652027
[TBL] [Abstract][Full Text] [Related]
26. Production and purification of refolded recombinant human IL-7 from inclusion bodies.
Ouellette T; Destrau S; Ouellette T; Zhu J; Roach JM; Coffman JD; Hecht T; Lynch JE; Giardina SL
Protein Expr Purif; 2003 Aug; 30(2):156-66. PubMed ID: 12880763
[TBL] [Abstract][Full Text] [Related]
27. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli.
Patra AK; Mukhopadhyay R; Mukhija R; Krishnan A; Garg LC; Panda AK
Protein Expr Purif; 2000 Mar; 18(2):182-92. PubMed ID: 10686149
[TBL] [Abstract][Full Text] [Related]
28. In situ protein folding and activation in bacterial inclusion bodies.
Gonzalez-Montalban N; Natalello A; García-Fruitós E; Villaverde A; Doglia SM
Biotechnol Bioeng; 2008 Jul; 100(4):797-802. PubMed ID: 18351678
[TBL] [Abstract][Full Text] [Related]
29. Formation of active inclusion bodies in the periplasm of Escherichia coli.
Arié JP; Miot M; Sassoon N; Betton JM
Mol Microbiol; 2006 Oct; 62(2):427-37. PubMed ID: 17020581
[TBL] [Abstract][Full Text] [Related]
30. Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.
Cabrita LD; Bottomley SP
Biotechnol Annu Rev; 2004; 10():31-50. PubMed ID: 15504702
[TBL] [Abstract][Full Text] [Related]
31. Chemical treatment of Escherichia coli: 3. Selective extraction of a recombinant protein from cytoplasmic inclusion bodies in intact cells.
Falconer RJ; O'Neill BK; Middelberg AP
Biotechnol Bioeng; 1999 Feb; 62(4):455-60. PubMed ID: 9921154
[TBL] [Abstract][Full Text] [Related]
32. Concepts and tools to exploit the potential of bacterial inclusion bodies in protein science and biotechnology.
Gatti-Lafranconi P; Natalello A; Ami D; Doglia SM; Lotti M
FEBS J; 2011 Jul; 278(14):2408-18. PubMed ID: 21569207
[TBL] [Abstract][Full Text] [Related]
33. [Recombinant protein production in Escherichia coli].
Nuc P; Nuc K
Postepy Biochem; 2006; 52(4):448-56. PubMed ID: 17536514
[TBL] [Abstract][Full Text] [Related]
34. Recovery of functionally-active protein from inclusion bodies using a thermal-cycling method.
Sadavarte R; Filipe CD; Ghosh R
Biotechnol Prog; 2017 Jan; 33(1):133-139. PubMed ID: 27690284
[TBL] [Abstract][Full Text] [Related]
35. Chaperones Promote Remarkable Solubilization of Salmonella enterica serovar Enteritidis Flagellin Expressed in Escherichia coli.
Bakhtiarvand B; Sadeghi Z; Tarahomjoo S; Yaghmaie S
Protein Pept Lett; 2020; 27(3):210-218. PubMed ID: 31566125
[TBL] [Abstract][Full Text] [Related]
36. Colony filtration blot: a new screening method for soluble protein expression in Escherichia coli.
Cornvik T; Dahlroth SL; Magnusdottir A; Herman MD; Knaust R; Ekberg M; Nordlund P
Nat Methods; 2005 Jul; 2(7):507-9. PubMed ID: 15973420
[TBL] [Abstract][Full Text] [Related]
37. Superactive β-galactosidase inclusion bodies.
Flores SS; Nolan V; Perillo MA; Sánchez JM
Colloids Surf B Biointerfaces; 2019 Jan; 173():769-775. PubMed ID: 30384274
[TBL] [Abstract][Full Text] [Related]
38. Recombinant protein folding and misfolding in Escherichia coli.
Baneyx F; Mujacic M
Nat Biotechnol; 2004 Nov; 22(11):1399-408. PubMed ID: 15529165
[TBL] [Abstract][Full Text] [Related]
39. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
Afzal AJ; Lightfoot DA
Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
[TBL] [Abstract][Full Text] [Related]
40. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
